Haemonetics Corporation ( HAE) - Key Metrics

HAE Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q4 ? ? ? ?
2026Q3 $7.24 $0.96 $2 $1.86
2026Q2 $6.88 $0.81 $2.34 $2.23
2026Q1 $6.68 $0.71 $0.36 $0.28
2025Q4 $6.72 $1.18 $2.37 $2.05

HAE Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q4 ? ?
2026Q3 ? 20.99
2026Q2 ? 14.81
2026Q1 ? 26.08
2025Q4 ? 13.48

HAE Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q4 2.13% ?
2026Q3 2.32% ?
2026Q2 4.64% ?
2026Q1 0.38% ?
2025Q4 3.23% ?

HAE

Price: $78.07

52 week price:
47.32
87.32

Earnings Per Share: 3.63 USD

P/E Ratio: 15.71

Exchange: NYQ

Sector: Healthcare

Industry: Medical Instruments & Supplies

Country: United States

Volume: 121503

Ebitda: 23.3 million

Market Capitalization: 3.4 billion

Links: